...
首页> 外文期刊>International journal of applied mechanics >Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their Outcome
【24h】

Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their Outcome

机译:早期和局部高级阶段喉癌及其结果的当前手术和非手术治疗策略的比较及其结果

获取原文
获取原文并翻译 | 示例
           

摘要

For the treatment of early and locally advanced glottic laryngeal cancer, multiple strategies are available. These are pursued and supported by different levels of evidence, but also by national and institutional traditions. The purpose of this review article is to compare and discuss the current evidence supporting different loco-regional treatment approaches in early and locally advanced glottic laryngeal cancer. The focus is kept on randomized controlled trials, meta-analyses, and comparative retrospective studies including the treatment period within the last twenty years (>= 1999) with at least one reported five-year oncologic and/or functional outcome measure. Based on the equipoise in oncologic and functional outcome after transoral laser surgery and radiotherapy, informed and shared decision-making with and not just about the patient poses a paramount importance for T1-2N0M0 glottic laryngeal cancer. For T3-4aN0-3M0 glottic laryngeal cancer, there is an equipoise regarding the partial /total laryngectomy and non-surgical modalities for T3 glottic laryngeal cancer. Patients with extensive and/or poorly functioning T4a laryngeal cancer should not be offered organ-preserving chemoradiotherapy with salvage surgery as a back-up plan, but total laryngectomy and adjuvant (chemo) radiation. The lack of high-level evidence comparing contemporary open or transoral robotic organ-preserving surgical and non-surgical modalities does not allow any concrete conclusions in terms of oncological and functional outcome. Unnecessary tri-modality treatments should be avoided. Instead of o ffering one-size-fits-all approaches and over-standardized rigid institutional strategies, patient-centered informed and shared decision-making should be favored.
机译:为了治疗早期和局部先进的浊声喉癌,可获得多种策略。这些是由不同级别的证据追求和支持,也是国家和体制传统。本综述文章的目的是比较和讨论在早期和当地先进的喉头癌症中支持不同基点 - 区域治疗方法的现有证据。该重点是随机对照试验,荟萃分析和比较回顾性研究,包括过去二十年(> = 1999)的治疗期,报告的五年肿瘤和/或功能结果措施至少有一个。基于经型激光手术和放射治疗后的肿瘤和功能结果的等级,信息和共同决策与患者不仅仅是患者对T1-2N0M0最小的喉癌至关重要。对于T3-4AN0-3M0喇叭性喉癌,有一种有关T3喉部喉癌的部分/总喉切除术和非手术方式的等价。不应向T4A喉癌功能繁多的患者,与抢救手术,作为备份计划,但喉部切除术和佐剂(化疗)辐射的全部喉部,患者。缺乏高级别的证据比较当代开放或传感器机器人器官保存的手术和非手术方式不允许在肿瘤学和功能结果方面进行任何具体结论。应避免不必要的三种方式处理。而不是呼吸一定尺寸的所有方法和过度标准化的刚性制度战略,患者以患者为中心的知情和共享决策应该受到青睐。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号